Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 22522050 approvals

GENOLUTION INC.

Official website

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

As of 2026-10-10, GENOLUTION INC. has 50 Korean MFDS device approvals, 16 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Products & technology

  • Nucleic acid extraction reagent kits (STD, HBV, HPV, TB/NTM, RV)Extracting nucleic acids (RNA/DNA) from human-derived samples
  • NX-48N, NX-DUO, NX-Junior, NX-32NAutomated nucleic acid extraction devices
  • long dsRNA synthesis productsSynthetic dsRNA for RNAi gene-silencing research
  • shRNA/siRNA synthesis serviceSynthesis service for RNAi research

Regulatory approvals

data.go.kr

50 Korean MFDS device approvals · 2013–2025

  • MFDSIVD reagents for extracting nucleic acids2025-07-08
    Product approval · Class 1체외 제신 25-867 호
  • MFDSIVD reagents for extracting nucleic acids2025-07-08
    Product approval · Class 1체외 제신 25-866 호
  • MFDSIVD reagents for extracting nucleic acids2025-07-08
    Product approval · Class 1체외 제신 25-865 호
  • MFDSIVD reagents for extracting nucleic acids2025-07-08
    Product approval · Class 1체외 제신 25-864 호
  • MFDSIVD reagents for extracting nucleic acids2025-03-11
    Product approval · Class 1체외 제신 25-296 호
  • MFDSIVD reagents for extracting nucleic acids2024-12-13
    Product approval · Class 1체외 제신 24-1555 호
  • MFDSIVD reagents for extracting nucleic acids2024-10-31
    Product approval · Class 1체외 제신 24-1338 호
  • MFDSIVD reagents for extracting nucleic acids2024-02-27
    Product approval · Class 1체외 제신 24-248 호
  • MFDSIVD reagents for extracting nucleic acids2024-02-20
    Product approval · Class 1체외 제신 24-216 호
  • MFDSIVD reagents for extracting nucleic acids2023-11-30
    Product approval · Class 1체외 제신 23-1708 호
  • MFDSExtractor, nucleic acid2023-09-27
    Product approval · Class 1체외 제신 23-1453 호
  • MFDSIVD reagents for extracting nucleic acids2023-09-20
    Product approval · Class 1체외 제신 23-1409 호
Show 38 more
  • MFDSIVD reagents for extracting nucleic acids2023-09-20
    Product approval · Class 1체외 제신 23-1406 호
  • MFDSIVD reagents for extracting nucleic acids2023-08-16
    Product approval · Class 1체외 제신 23-1243 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-16
    Product approval · Class 1체외 제신 23-932 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-16
    Product approval · Class 1체외 제신 23-931 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-16
    Product approval · Class 1체외 제신 23-929 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-16
    Product approval · Class 1체외 제신 23-928 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-16
    Product approval · Class 1체외 제신 23-924 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-16
    Product approval · Class 1체외 제신 23-923 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-07
    Product approval · Class 1체외 제신 23-895 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-07
    Product approval · Class 1체외 제신 23-894 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-07
    Product approval · Class 1체외 제신 23-893 호
  • MFDSIVD reagents for extracting nucleic acids2023-04-17
    Product approval · Class 1체외 제신 23-658 호
  • MFDSIVD reagents for extracting nucleic acids2023-04-17
    Product approval · Class 1체외 제신 23-655 호
  • MFDSIVD reagents for extracting nucleic acids2023-04-07
    Product approval · Class 1체외 제신 23-626 호
  • MFDSIVD reagents for extracting nucleic acids2023-04-07
    Product approval · Class 1체외 제신 23-625 호
  • MFDSIVD reagents for extracting nucleic acids2023-04-07
    Product approval · Class 1체외 제신 23-624 호
  • MFDSIVD reagents for extracting nucleic acids2022-10-26
    Product approval · Class 1체외 제신 22-1483 호
  • MFDSIVD reagents for extracting nucleic acids2022-10-26
    Product approval · Class 1체외 제신 22-1482 호
  • MFDSIVD reagents for extracting nucleic acids2022-10-26
    Product approval · Class 1체외 제신 22-1481 호
  • MFDSIVD reagents for extracting nucleic acids2022-10-26
    Product approval · Class 1체외 제신 22-1480 호
  • MFDSIVD reagents for extracting nucleic acids2022-10-26
    Product approval · Class 1체외 제신 22-1479 호
  • MFDSIVD reagents for extracting nucleic acids2022-10-26
    Product approval · Class 1체외 제신 22-1478 호
  • MFDSExtractor, nucleic acid2022-09-22
    Product approval · Class 1체외 제신 22-1319 호
  • MFDSIVD reagents for extracting nucleic acids2022-05-04
    Product approval · Class 1체외 제신 22-618 호
  • MFDSIVD reagents for extracting nucleic acids2022-05-04
    Product approval · Class 1체외 제신 22-617 호
  • MFDSIVD reagents for extracting nucleic acids2022-05-04
    Product approval · Class 1체외 제신 22-616 호
  • MFDSIVD reagents for extracting nucleic acids2022-05-04
    Product approval · Class 1체외 제신 22-615 호
  • MFDSIVD reagents for extracting nucleic acids2022-05-04
    Product approval · Class 1체외 제신 22-614 호
  • MFDSIVD reagents for extracting nucleic acids2022-05-04
    Product approval · Class 1체외 제신 22-613 호
  • MFDSIVD reagents for extracting nucleic acids2022-02-09
    Product approval · Class 1체외 제신 22-171 호
  • MFDSIVD reagents for extracting nucleic acids2022-02-09
    Product approval · Class 1체외 제신 22-169 호
  • MFDSExtractor, nucleic acid2022-01-19
    Product approval · Class 1체외 제신 22-88 호
  • MFDSExtractor, nucleic acid2021-09-28
    Product approval · Class 1체외 제신 21-1296 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2015-01-16
    Product approval · Class 3체외 제허 15-60 호
  • MFDSIVD reagents for extracting nucleic acids2014-09-12
    Product approval · Class 1서울 체외 제신 14-360 호
  • MFDSIVD reagents for extracting nucleic acidsRevoked2014-01-24
    Product approval · Class 1서울 체외 제신 14-54 호
  • MFDSExtractor, nucleic acid2014-01-24
    Product approval · Class 1경인 체외 제신 14-66 호
  • MFDSIVD reagents for extracting nucleic acids2013-08-08
    Product approval · Class 1서울 체외 제신 13-221 호

R&D and key agreements

Source: DART corporate disclosure

마그네틱 비드 관련 특허 · 특허출원 · Filed a patent related to magnetic beads, a key raw material for nucleic acid extraction reagents, to reduce costs.

전자동 분자진단 장비 · 개발중 · Developing a fully automated molecular diagnostic device covering the process from sample input to PCR preparation.

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched
Show 6 more publications

Patents

KIPRIS · applicant-matched
Show 12 more patents

AI reads

MAA server logs · IP-verified
207
Times AI engines pulled GENOLUTION INC.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

207
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

10
live 0
Last 7 days
159
live 0
Last 30 days
207
live 0
All time
  • OpenAIOAI-SearchBot153
  • GoogleGoogleOther41
  • PerplexityPerplexityBot10
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for GENOLUTION INC. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Boditech Med Inc.3 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

AHN-GOOK PHARMACEUTICAL Co., Ltd.3 shared

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

OSANG HEALTHCARE CO.,LTD.3 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

iNtRON Biotechnology, Inc.3 shared

Founded in 1999 and listed on KOSDAQ in 2011, iNtRON Biotechnology develops bacteriophage-based new drugs via its itLysin and IMPA platforms alongside a molecular diagnostics business.

RollingStone Co., Ltd.3 shared

KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.

BIONEERCORPORATION3 shared

Bioneer, founded in 1992 and KOSDAQ-listed in 2005, provides gene analysis equipment, molecular diagnostics, and RNAi drug development.

HLB PANAGENE Co., LTD.3 shared

Founded in 1976 and KOSDAQ-listed in 2000, HLB PANAGENE develops PNA-based molecular diagnostic and diagnostic automation products.

Access Bio, Inc.3 shared

Founded in 2002 and KOSDAQ-listed in 2013, Access Bio develops rapid diagnostic tests for malaria, COVID-19, and other infectious diseases.

SEEGENE, INC.3 shared

Founded in 2000 and KOSDAQ-listed in 2010, Seegene develops syndromic multiplex PCR molecular diagnostic reagents.

CALTH. Inc3 shared

Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.

Genesystem Co., Ltd3 shared

Founded 2010, listed on KOSDAQ in 2021, Genesystem develops molecular diagnostic systems, biochips, test kits, and reaction reagents.

NanoenTek,Inc.2 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition